1. Home
  2. FSFG vs ACRS Comparison

FSFG vs ACRS Comparison

Compare FSFG & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSFG
  • ACRS
  • Stock Information
  • Founded
  • FSFG 2008
  • ACRS 2012
  • Country
  • FSFG United States
  • ACRS United States
  • Employees
  • FSFG N/A
  • ACRS N/A
  • Industry
  • FSFG Savings Institutions
  • ACRS Biotechnology: Pharmaceutical Preparations
  • Sector
  • FSFG Finance
  • ACRS Health Care
  • Exchange
  • FSFG Nasdaq
  • ACRS Nasdaq
  • Market Cap
  • FSFG 177.8M
  • ACRS 165.7M
  • IPO Year
  • FSFG 2008
  • ACRS 2015
  • Fundamental
  • Price
  • FSFG $27.02
  • ACRS $1.81
  • Analyst Decision
  • FSFG Strong Buy
  • ACRS Strong Buy
  • Analyst Count
  • FSFG 3
  • ACRS 9
  • Target Price
  • FSFG $31.50
  • ACRS $9.25
  • AVG Volume (30 Days)
  • FSFG 8.2K
  • ACRS 800.9K
  • Earning Date
  • FSFG 10-23-2025
  • ACRS 11-05-2025
  • Dividend Yield
  • FSFG 2.37%
  • ACRS N/A
  • EPS Growth
  • FSFG 130.94
  • ACRS N/A
  • EPS
  • FSFG 3.10
  • ACRS N/A
  • Revenue
  • FSFG $79,674,000.00
  • ACRS $16,789,000.00
  • Revenue This Year
  • FSFG N/A
  • ACRS N/A
  • Revenue Next Year
  • FSFG $7.37
  • ACRS N/A
  • P/E Ratio
  • FSFG $8.70
  • ACRS N/A
  • Revenue Growth
  • FSFG 10.53
  • ACRS N/A
  • 52 Week Low
  • FSFG $21.63
  • ACRS $1.05
  • 52 Week High
  • FSFG $30.94
  • ACRS $5.17
  • Technical
  • Relative Strength Index (RSI)
  • FSFG 51.08
  • ACRS 44.83
  • Support Level
  • FSFG $26.67
  • ACRS $2.01
  • Resistance Level
  • FSFG $27.67
  • ACRS $2.16
  • Average True Range (ATR)
  • FSFG 0.57
  • ACRS 0.11
  • MACD
  • FSFG -0.08
  • ACRS -0.03
  • Stochastic Oscillator
  • FSFG 48.20
  • ACRS 1.43

About FSFG First Savings Financial Group Inc.

First Savings Financial Group Inc provides various banking services to individuals and business customers in southern Indiana. The bank accepts deposits from the general public & uses those funds, along with other borrowings, mainly to originate a residential mortgage, commercial mortgage, construction, commercial business, & consumer loans, and to a lesser extent, to invest in mortgage-backed securities and other debt securities. The company conducts lending and deposit activities mainly with individuals and small businesses in its market area. The bank operates in two segments: core banking, which accounts for the majority of revenue, and SBA lending.

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

Share on Social Networks: